FundedIQ
Biotechnology

AgNovos Bioscience: Funding, Investors & Team (Oct 2026)

AgNovos Bioscience develops new medical technology products leveraging regenerative medicine to address the local effects of bone disease. The company has conducted extensive pre-clinical and clinical research on its first treatment, OSSURE™ LOEP (Local Osteo-Enhancement Procedure).

www.agnovos.com Rockville, United States 51-100 employees
Biotechnology Health Care Medical Medical Device
Total raised
$31.5M
Rounds
1
Latest
Undisclosed round
Jun 2023

AgNovos Bioscience has raised $31.5M across 1 funding round on record, the most recent an undisclosed round of $31.5M announced in Jun 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AgNovos Bioscience Company Profile and Key Stats

Total funding raised
$31.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$31.5M in Jun 2023
Employees
51-100
reported band
Headquarters
Rockville, United States

Latest funding round on record: Jun 2023.

AgNovos Bioscience Funding Rounds

Date
Round
Amount
Undisclosed round
$31.5M

AgNovos Bioscience Founders and Leadership Team

Name
Role
Contact
James Howe
Founder
Locked

Contact details for the AgNovos Bioscience team: 1 of 1 has an email address on file.

Start 14-day free trial →

AgNovos Bioscience Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

AgNovos Bioscience's latest round of $31.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AgNovos Bioscience in Biotechnology and Rockville

Companies Similar to AgNovos Bioscience

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

AgNovos Bioscience Funding FAQs

What does AgNovos Bioscience do?

AgNovos Bioscience develops new medical technology products leveraging regenerative medicine to address the local effects of bone disease. The company has conducted extensive pre-clinical and clinical research on its first treatment, OSSURE™ LOEP (Local Osteo-Enhancement Procedure).

How much funding has AgNovos Bioscience raised?

AgNovos Bioscience has raised $31.5M across 1 round on record. The most recent is an undisclosed round of $31.5M announced in Jun 2023.

When did AgNovos Bioscience last raise funding?

AgNovos Bioscience's most recent funding round on record is an undisclosed round of $31.5M, announced in Jun 2023.

Who founded AgNovos Bioscience?

FundedIQ lists James Howe (Founder) at AgNovos Bioscience.

Where is AgNovos Bioscience headquartered?

AgNovos Bioscience is based in Rockville, Maryland, United States.

How many employees does AgNovos Bioscience have?

AgNovos Bioscience is in the 51-100 employee band.

How does AgNovos Bioscience's funding compare to other Biotechnology startups?

AgNovos Bioscience's latest round of $31.5M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's AgNovos Bioscience Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AgNovos Bioscience is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.